What should you know about IV exosome therapy?

Exosomes are small membrane-bound particles released by cells that can carry proteins and genetic signals. In a drip, a prepared product is introduced through a cannula under supervision. The label may sound precise, but products can differ in their source, processing, contents, sterility, and intended use. Claims about skin rejuvenation or whole-body benefits should therefore be examined carefully rather than assumed from the name.

IV delivery also exposes the whole body, not only a selected patch of skin. A clinician should first decide whether the proposed goal has a recognised diagnosis and whether a better-established option is available.

Request the product name, source, preparation details, intended purpose, and information about quality testing. Ask who is medically responsible and how allergic reactions, infection, or infusion problems would be handled. Provide your full history, including immune conditions, allergies, pregnancy, cancer treatment, and medicines. During administration, report itching, wheeze, dizziness, chest discomfort, fever, or pain and swelling at the cannula site immediately.

Seek emergency help for difficulty breathing, face or throat swelling, fainting, severe chest pain, or widespread hives. Arrange prompt medical review for fever, chills, worsening weakness, persistent vomiting, or increasing redness and pain around the cannula site. Delayed symptoms after an infusion should still be reported, especially if they are new or worsening.

Ask what evidence supports the proposed goal, what is actually in the preparation, how it was handled, and what alternatives have clearer safety information. Confirm expected monitoring, possible interactions with your treatment, warning symptoms, and who will provide follow-up.